Cubist Systematic Strategies’s Cardiff Oncology CRDF Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$183K	Buy	+88,903	New	+$246K	﹤0.01%	2676
2024 Q3	–	Sell	-68,730	Closed	-$153K	–	3054
2024 Q2	$153K	Buy	68,730 +36,441	+113%	+$137K	﹤0.01%	2563
2024 Q1	$172K	Buy	+32,289	New	+$85.8K	﹤0.01%	3140
2022 Q2	–	Sell	-69,090	Closed	-$171K	–	4384
2022 Q1	$171K	Buy	69,090 +59,639	+631%	+$211K	﹤0.01%	3093
2021 Q4	$57K	Sell	9,451 -16,233	-63%	-$96.8K	﹤0.01%	3292
2021 Q3	$171K	Sell	25,684 -21,660	-46%	-$136K	﹤0.01%	2629
2021 Q2	$315K	Sell	47,344 -44,679	-49%	-$379K	﹤0.01%	2294
2021 Q1	$852K	Buy	92,023 +25,334	+38%	+$308K	0.01%	1636
2020 Q4	$1.2M	Buy	+66,689	New	+$1.17M	0.02%	1260